Jeremy D. Broekhuis

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Imaging-Guided Live Single-Cell Lipid Profiling of Leader and Follower Cells During Collective Migration of Triple-Negative Breast Cancer Cells.

Imaging-Guided Live Single-Cell Lipid Profiling of Leader and Follower Cells During Collective Migration of Triple-Negative Breast Cancer Cells.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 05, 2026

Maternal anti-HPA-1a antibodies block αIIbβ3 and αvβ3 integrin activation which correlates with FNAIT disease severity.

Maternal anti-HPA-1a antibodies block αIIbβ3 and αvβ3 integrin activation which correlates with FNAIT disease severity.

Journal: Blood

Published: September 16, 2025

Maternal anti-HPA-1a antibodies block αIIbβ3/αvβ3 integrin activation, and blockade correlates with FNAIT disease severity.

Maternal anti-HPA-1a antibodies block αIIbβ3/αvβ3 integrin activation, and blockade correlates with FNAIT disease severity.

Journal: Blood

Published: September 16, 2025

Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2).

Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2).

Journal: International journal of molecular sciences

Published: July 18, 2024

Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor.

Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor.

Journal: Biochemical pharmacology

Published: October 01, 2023

Corrigendum to "Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism" [Biochem. Pharmacol. 208 (2023) 115399].

Corrigendum to "Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism" [Biochem. Pharmacol. 208 (2023) 115399].

Journal: Biochemical pharmacology

Published: February 12, 2023

Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism.

Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism.

Journal: Biochemical pharmacology

Published: October 14, 2022

A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.

A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.

Journal: Scientific reports

Published: September 17, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026